Fresenius Medical Care AG/ DE0005785802 /
2024-04-19 4:20:32 PM | Chg. +0.30 | Volume | Bid4:20:38 PM | Ask4:20:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.66EUR | +0.83% | 191,739 Turnover: 2.49 mill. |
36.62Bid Size: 106 | 36.65Ask Size: 392 | 10.63 bill.EUR | 3.28% | 21.31 |
GlobeNewswire
02-23
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
02-04
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
2023-09-04
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
2023-08-31
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
2023-08-24
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
2022-03-29
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
2022-03-14
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2022-03-01
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2022-02-28
Humacyte Announces Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV™ for H...
GlobeNewswire
2022-02-25
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire
2022-02-24
OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
GlobeNewswire
2022-02-24
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire
2022-01-31
Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to...